Brexucabtagene autoleucel (Tecartus) has become the first CAR T-cell therapy approved to treat adults with B-cell precursor acute lymphoblastic leukemia (ALL). On October 1, FDA approved Tecartus for adults with ALL that not responded to treatment (refractory) or has returned after treatment (relapsed).

For children with the eye cancer retinoblastoma, researchers are studying a CAR T-cell therapy in which the engineered immune cells are packaged in a biodegradable material called a hydrogel and then injected directly into tumors. The treatment showed promise when tested in mice.

A remodeled CAR T-cell therapy causes fewer neurologic side effects and is equally effective as the original form of the therapy, according to results from the first clinical trial of the treatment in patients with B-cell lymphomas. The CAR T-cell targets the CD19 antigen on cancer cells.

A Cancer Currents blog post on a study showing that patient-reported outcomes, or PROs, can be successfully collected during cancer clinical trials

NCI is developing the capability to produce cellular therapies, like CAR T cells, to be tested in cancer clinical trials at multiple hospital sites. Few laboratories and centers have the capability to make CAR T cells, which has limited the ability to test them more broadly.

This illustration shows the steps for creating CAR T-cell therapy, a type of treatment in which a patient's T cells (a type of immune system cell) are changed in the laboratory so they will attack cancer cells.

Intelligent search from Bing makes it easier to quickly find what you’re looking for and rewards you.

Intelligent search from Bing makes it easier to quickly find what you’re looking for and rewards you.

Intelligent search from Bing makes it easier to quickly find what you’re looking for and rewards you.

Intelligent search from Bing makes it easier to quickly find what you’re looking for and rewards you.

Intelligent search from Bing makes it easier to quickly find what you’re looking for and rewards you.

Intelligent search from Bing makes it easier to quickly find what you’re looking for and rewards you.

Intelligent search from Bing makes it easier to quickly find what you’re looking for and rewards you.

Intelligent search from Bing makes it easier to quickly find what you’re looking for and rewards you.

Intelligent search from Bing makes it easier to quickly find what you’re looking for and rewards you.

The cytokine interleukin (IL)-1β is a key mediator of the inflammatory response and has been implicated in the pathophysiology of acute and chronic inflammation

One of the characteristics of systemic lupus erythematosus (SLE) is the large inter- and intra-individual variability of the clinical course. Lupus nephritis is no exception. Some patients with kidney involvement may show rapid progression to renal failure, others may enter complete and stable remis …

Primary biliary cirrhosis (PBC) is a chronic, progressive cholestatic liver disease, which is invariably fatal. Circumstantial and indirect evidence suggests that autoimmune mechanisms have a role in the pathogenesis of PBC. Antimitochondrial antibodies (AMA) are highly sensitive and specific marker …

Transplantation of MHC-compatible, T-cell-depleted, bone marrow cells has successfully treated autoimmunities, immunodeficiencies, malignancies, and developmental deficiencies of the hematopoietic system. Recombinant inbred SCG/Kj mice develop spontaneous crescentic glomerulonephritis, systemic vasc …

Paracrine effect of transforming growth factor-beta1 (TGF-beta1) on autoimmune insulitis and diabetes was studied by transgenic production of the active form of porcine TGF-beta1 (pTGF-beta1) in pancreatic islet (islet) alpha cells in nonobese diabetic (NOD) mice under the control of rat glucagon pr …

On the basis of the positive outcome of animal experiments, several large placebo-controlled trials are underway and aiming for the first time at the prevention of an immune-mediated disease, type 1 diabetes. The first of these trials, The Deutsche Nicotinamide Intervention Study (DENIS), evaluated …

Gallium nitrate (GN) has been shown to inhibit T cell-mediated inflammatory disease. The purpose of our study was to test the effect of gallium nitrate (GN) on experimental autoimmune uveitis (EAU). Experimental autoimmune uveitis was induced in male Lewis rats immunized with retinal S-antigen. Rats …

Gallium (Ga) nitrate, a drug which prevents a variety of experimental autoimmune diseases, was investigated in a murine model of systemic lupus erythematosus (SLE). In one experiment, female MRL/Mp lpr/lpr (MRL/lpr) mice were randomized into 2 groups of 6: 1) vehicle (trisodium citrate) and 2) Ga. S …